Peter DiRoma

General Counsel at RA PHARMACEUTICALS, INC.

Health Technology

Consumer Services

Profile

Peter DiRoma is a professional with experience in regulatory affairs and quality assurance.
He is currently the Senior VP-Regulatory, Quality & Government Affairs at Ra Pharmaceuticals, Inc. Prior to this, he held positions as Vice President-Regulatory Affairs at Merck KGaA, EMD Serono, Inc., and Vice President-Global Regulatory Affairs at Dendreon Corp.
He also served as Senior VP-Regulatory Affairs & Quality Assurance at Melinta Therapeutics, Inc. and VP-Regulatory Affairs & Quality Assurance at Melinta Subsidiary Corp.
Mr. DiRoma received his undergraduate degree from the University of South Florida.

Peter DiRoma active positions

Companies	Position	Start
RA PHARMACEUTICALS, INC.	General Counsel	2018-10-31

All active positions of Peter DiRoma

Former positions of Peter DiRoma

Companies	Position	End
MELINTA THERAPEUTICS, INC.	General Counsel	2018-08-31
EMD Serono, Inc. EMD Serono, Inc. Pharmaceuticals: MajorHealth Technology Develops recombinant prescription medicines	General Counsel	-
MERCK KGAA	General Counsel	-
DENDREON CORPORATION	General Counsel	-
Melinta Subsidiary Corp. Melinta Subsidiary Corp. Pharmaceuticals: MajorHealth Technology Develops and markets pharmaceutical products for the treatment of life-threatening infections	General Counsel	-

See the detail of Peter DiRoma's experience

Training of Peter DiRoma

Experiences
Positions held

Active

Inactive

Listed companies

Private companies

See the detail of Peter DiRoma's experience

Connections

1st degree connections

1st degree companies

Male

Female

Members of the board

Executives

See the personal network

Linked companies

Private companies	7
Merck KGaA Merck KGaA Pharmaceuticals: MajorHealth Technology Engages in the manufacturing of pharmaceutical and chemical products	Health Technology
Dendreon Corp. Dendreon Corp. Medical SpecialtiesHealth Technology Discovers, develops and commercializes novel products for the treatment of cancer	Health Technology
Ra Pharmaceuticals, Inc. Ra Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Develops drugs for the treatment of glomerulonephritis, kidney disease and cardiovascular disease	Health Technology
University of South Florida University of South Florida Other Consumer ServicesConsumer Services Functions as a College/University	Consumer Services
Melinta Subsidiary Corp. Melinta Subsidiary Corp. Pharmaceuticals: MajorHealth Technology Develops and markets pharmaceutical products for the treatment of life-threatening infections	Health Technology
EMD Serono, Inc. EMD Serono, Inc. Pharmaceuticals: MajorHealth Technology Develops recombinant prescription medicines	Health Technology
Melinta Therapeutics, Inc. Melinta Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Operates as a commercial-stage company and develops innovative therapies for acute and life-threatening illnesses	Health Technology